Immune Checkpoint Inhibitor-Related Alopecia: Insight into the Pathophysiology Using Non-Invasive Diagnostic Techniques

The letter to the editor discussed the pathophysiology of immune checkpoint inhibitor-related alopecia using non-invasive diagnostic techniques. The authors, Misaki Kinoshita-Ise and colleagues, provided insights into how these treatments, which are used in cancer therapy, can lead to hair loss. They emphasized the importance of understanding the underlying mechanisms to better manage and potentially mitigate this side effect. The study highlighted the use of advanced diagnostic tools to observe changes in hair follicles and scalp conditions without the need for invasive procedures.